vs
DocGo Inc.(DCGO)与LifeStance Health Group, Inc.(LFST)财务数据对比。点击上方公司名可切换其他公司
LifeStance Health Group, Inc.的季度营收约是DocGo Inc.的5.1倍($382.2M vs $74.9M)。LifeStance Health Group, Inc.净利率更高(3.1% vs -190.0%,领先193.0%)。LifeStance Health Group, Inc.同比增速更快(17.4% vs -38.0%)。LifeStance Health Group, Inc.自由现金流更多($46.6M vs $-12.0M)。过去两年LifeStance Health Group, Inc.的营收复合增速更高(12.8% vs -37.5%)
DocGo Inc.是总部位于美国的移动医疗及按需医疗服务提供商,业务覆盖上门急诊、检测诊断、远程问诊、企业健康管理等领域,服务对象涵盖个人患者、医疗机构、企业客户及公共部门,主要市场为北美地区。
LifeStance Health Group是美国的门诊行为健康服务提供商,支持线下面诊与远程诊疗两种服务模式,业务涵盖心理咨询、精神科诊疗、经颅磁刺激(TMS)以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
DCGO vs LFST — 直观对比
营收规模更大
LFST
是对方的5.1倍
$74.9M
营收增速更快
LFST
高出55.4%
-38.0%
净利率更高
LFST
高出193.0%
-190.0%
自由现金流更多
LFST
多$58.6M
$-12.0M
两年增速更快
LFST
近两年复合增速
-37.5%
损益表 — Q4 2025 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $74.9M | $382.2M |
| 净利润 | $-142.3M | $11.7M |
| 毛利率 | — | — |
| 营业利润率 | -139.6% | 4.7% |
| 净利率 | -190.0% | 3.1% |
| 营收同比 | -38.0% | 17.4% |
| 净利润同比 | -1761.4% | 264.1% |
| 每股收益(稀释后) | $-1.36 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DCGO
LFST
| Q4 25 | $74.9M | $382.2M | ||
| Q3 25 | $70.8M | $363.8M | ||
| Q2 25 | $80.4M | $345.3M | ||
| Q1 25 | $96.0M | $333.0M | ||
| Q4 24 | $120.8M | $325.5M | ||
| Q3 24 | $138.7M | $312.7M | ||
| Q2 24 | $164.9M | $312.3M | ||
| Q1 24 | $192.1M | $300.4M |
净利润
DCGO
LFST
| Q4 25 | $-142.3M | $11.7M | ||
| Q3 25 | $-27.8M | $1.1M | ||
| Q2 25 | $-11.2M | $-3.8M | ||
| Q1 25 | $-9.4M | $709.0K | ||
| Q4 24 | $-7.6M | $-7.1M | ||
| Q3 24 | $5.5M | $-6.0M | ||
| Q2 24 | $6.5M | $-23.3M | ||
| Q1 24 | $11.2M | $-21.1M |
营业利润率
DCGO
LFST
| Q4 25 | -139.6% | 4.7% | ||
| Q3 25 | -59.3% | 2.0% | ||
| Q2 25 | -21.7% | -0.9% | ||
| Q1 25 | -14.6% | 0.5% | ||
| Q4 24 | -6.2% | 0.3% | ||
| Q3 24 | 7.3% | 0.0% | ||
| Q2 24 | 6.2% | -5.1% | ||
| Q1 24 | 8.3% | -5.6% |
净利率
DCGO
LFST
| Q4 25 | -190.0% | 3.1% | ||
| Q3 25 | -39.2% | 0.3% | ||
| Q2 25 | -13.9% | -1.1% | ||
| Q1 25 | -9.8% | 0.2% | ||
| Q4 24 | -6.3% | -2.2% | ||
| Q3 24 | 4.0% | -1.9% | ||
| Q2 24 | 4.0% | -7.5% | ||
| Q1 24 | 5.8% | -7.0% |
每股收益(稀释后)
DCGO
LFST
| Q4 25 | $-1.36 | — | ||
| Q3 25 | $-0.28 | — | ||
| Q2 25 | $-0.11 | — | ||
| Q1 25 | $-0.09 | — | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $0.05 | — | ||
| Q2 24 | $0.06 | — | ||
| Q1 24 | $0.10 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $51.0M | $248.6M |
| 总债务越低越好 | $235.6K | $282.8M |
| 股东权益账面价值 | $144.0M | $1.5B |
| 总资产 | $217.1M | $2.2B |
| 负债/权益比越低杠杆越低 | 0.00× | 0.19× |
8季度趋势,按日历期对齐
现金及短期投资
DCGO
LFST
| Q4 25 | $51.0M | $248.6M | ||
| Q3 25 | $73.4M | $203.9M | ||
| Q2 25 | $104.2M | $188.9M | ||
| Q1 25 | $79.0M | $134.3M | ||
| Q4 24 | $89.2M | $154.6M | ||
| Q3 24 | $89.5M | $102.6M | ||
| Q2 24 | $66.1M | $87.0M | ||
| Q1 24 | $41.2M | $49.5M |
总债务
DCGO
LFST
| Q4 25 | $235.6K | $282.8M | ||
| Q3 25 | $249.9K | $284.6M | ||
| Q2 25 | $12.6K | $286.4M | ||
| Q1 25 | $15.1K | $288.2M | ||
| Q4 24 | $17.7K | $290.0M | ||
| Q3 24 | $47.7K | $287.3M | ||
| Q2 24 | $52.8K | $288.0M | ||
| Q1 24 | $60.1K | $288.8M |
股东权益
DCGO
LFST
| Q4 25 | $144.0M | $1.5B | ||
| Q3 25 | $270.5M | $1.5B | ||
| Q2 25 | $297.3M | $1.5B | ||
| Q1 25 | $309.3M | $1.5B | ||
| Q4 24 | $320.9M | $1.4B | ||
| Q3 24 | $325.2M | $1.4B | ||
| Q2 24 | $315.2M | $1.4B | ||
| Q1 24 | $311.3M | $1.4B |
总资产
DCGO
LFST
| Q4 25 | $217.1M | $2.2B | ||
| Q3 25 | $353.8M | $2.1B | ||
| Q2 25 | $408.3M | $2.1B | ||
| Q1 25 | $430.8M | $2.1B | ||
| Q4 24 | $455.6M | $2.1B | ||
| Q3 24 | $493.9M | $2.1B | ||
| Q2 24 | $488.2M | $2.1B | ||
| Q1 24 | $490.7M | $2.1B |
负债/权益比
DCGO
LFST
| Q4 25 | 0.00× | 0.19× | ||
| Q3 25 | 0.00× | 0.19× | ||
| Q2 25 | 0.00× | 0.19× | ||
| Q1 25 | 0.00× | 0.20× | ||
| Q4 24 | 0.00× | 0.20× | ||
| Q3 24 | 0.00× | 0.20× | ||
| Q2 24 | 0.00× | 0.20× | ||
| Q1 24 | 0.00× | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-10.5M | $57.6M |
| 自由现金流经营现金流 - 资本支出 | $-12.0M | $46.6M |
| 自由现金流率自由现金流/营收 | -16.0% | 12.2% |
| 资本支出强度资本支出/营收 | 2.0% | 2.9% |
| 现金转化率经营现金流/净利润 | — | 4.93× |
| 过去12个月自由现金流最近4个季度 | $29.9M | $110.0M |
8季度趋势,按日历期对齐
经营现金流
DCGO
LFST
| Q4 25 | $-10.5M | $57.6M | ||
| Q3 25 | $1.7M | $27.3M | ||
| Q2 25 | $33.6M | $64.4M | ||
| Q1 25 | $9.7M | $-3.1M | ||
| Q4 24 | $12.7M | $62.3M | ||
| Q3 24 | $31.1M | $22.7M | ||
| Q2 24 | $36.9M | $44.1M | ||
| Q1 24 | $-10.6M | $-21.8M |
自由现金流
DCGO
LFST
| Q4 25 | $-12.0M | $46.6M | ||
| Q3 25 | $782.6K | $17.0M | ||
| Q2 25 | $32.9M | $56.6M | ||
| Q1 25 | $8.2M | $-10.3M | ||
| Q4 24 | $12.0M | $56.0M | ||
| Q3 24 | $30.2M | $17.7M | ||
| Q2 24 | $35.9M | $39.0M | ||
| Q1 24 | $-11.6M | $-26.9M |
自由现金流率
DCGO
LFST
| Q4 25 | -16.0% | 12.2% | ||
| Q3 25 | 1.1% | 4.7% | ||
| Q2 25 | 40.9% | 16.4% | ||
| Q1 25 | 8.5% | -3.1% | ||
| Q4 24 | 9.9% | 17.2% | ||
| Q3 24 | 21.8% | 5.7% | ||
| Q2 24 | 21.7% | 12.5% | ||
| Q1 24 | -6.0% | -9.0% |
资本支出强度
DCGO
LFST
| Q4 25 | 2.0% | 2.9% | ||
| Q3 25 | 1.2% | 2.8% | ||
| Q2 25 | 0.9% | 2.2% | ||
| Q1 25 | 1.5% | 2.2% | ||
| Q4 24 | 0.6% | 1.9% | ||
| Q3 24 | 0.7% | 1.6% | ||
| Q2 24 | 0.6% | 1.6% | ||
| Q1 24 | 0.5% | 1.7% |
现金转化率
DCGO
LFST
| Q4 25 | — | 4.93× | ||
| Q3 25 | — | 25.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -4.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.67× | — | ||
| Q2 24 | 5.65× | — | ||
| Q1 24 | -0.95× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DCGO
| Transportation Services Segment | $50.2M | 67% |
| Mobile Health Services Segment | $24.8M | 33% |
LFST
暂无分部数据